Showing results (271-280 of 491) with videos related to

Sort By:
Pageof 50
European Heart Journal|August 21, 2008
Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromesAndrzej Budaj, John W Eikelboom, Shamir R Mehta, et al.
American Heart Journal|August 13, 2011
Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromesBasem Elbarouni, Nabeel Ismaeil, Raymond T Yan, et al.
Journal of the American College of Cardiology|June 29, 2019
Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS TrialSonia S Anand, John W Eikelboom, Leanne Dyal, et al.
European Heart Journal|September 11, 2019
Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trialTamar I de Vries, John W Eikelboom, Jackie Bosch, et al.
American Heart Journal|March 1, 2006
The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE)Shaun G Goodman, Philippe Gabriel Steg, Kim A Eagle, et al.
Clinical Cardiology|May 14, 2016
Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS TrialEmil Hagström, Matthew T Roe, Gail Hafley, et al.
European Journal of Heart Failure|August 19, 2003
A prognostic index to predict long-term mortality in patients with mild to moderate chronic heart failure stabilised on angiotensin converting enzyme inhibitorsMark T Kearney, James Nolan, Amanda J Lee, et al.
European Heart Journal|June 10, 2020
Performance of the GRACE 2.0 score in patients with type 1 and type 2 myocardial infarctionJohn Hung, Andreas Roos, Erik Kadesjö, et al.
American Heart Journal|May 13, 2015
Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trialMichelle L O'Donoghue, Ruchira Glaser, Philip E Aylward, et al.
Open Heart|June 26, 2025
Effectiveness of the GRACE risk score according to troponin elevation in patients admitted with non-ST elevation acute coronary syndrome: a post hoc analysis of the UKGRIS parallel group cluster randomised controlled trialChris P Gale, Deborah Stocken, Ramesh Nadarajah, et al.
Pageof 50